LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

Inicio・Lista de Acciones・Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc

Cerrado

SectorSanidad

1.4 -0.71

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.38

Máximo

1.44

Métricas clave
By Trading Economics
Ingresos	-16M -13M
Ventas	-15M 14M
BPA	-0.04
Margen de beneficios	-90.037
Empleados	103
EBITDA	-16M -10M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+179.58% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	494M
Apertura anterior	2.11
Cierre anterior	1.4

Noticias sobre sentimiento de mercado

By Acuity

50%

184 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

0.6863 / 0.72 Soporte y Resistencia

Lexicon Pharmaceuticals Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 dic 2025, 21:08 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms Buys AI-Device Maker Limitless

5 dic 2025, 19:39 UTC

Principales Movimientos del Mercado

Parsons' FAA Bid Loss Clouds Outlook After Rocky Year for Contractors

5 dic 2025, 19:17 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy Agrees to Divest Assets to Finalize Calpine Deal

5 dic 2025, 21:59 UTC

Adquisiciones, fusiones, absorciones

Netflix's Megadeal Will Need the Trump Administration's Blessing -- Update

5 dic 2025, 21:50 UTC

Charlas de Mercado

Ganancias

Financial Services Roundup: Market Talk

5 dic 2025, 21:50 UTC

Adquisiciones, fusiones, absorciones

The Netflix and Warner Bros. Deal Is Far From a Sure Thing -- Barrons.com

5 dic 2025, 21:36 UTC

Charlas de Mercado

Return of Shipping to Red Sea a Step Closer, Xeneta Says -- Market Talk

5 dic 2025, 21:35 UTC

Adquisiciones, fusiones, absorciones

The Netflix-Warner Bros. Deal Has a Wildcard. How Paramount Could Still Win. -- Barrons.com

5 dic 2025, 21:26 UTC

Adquisiciones, fusiones, absorciones

Warner Bros. Discovery and Netflix Enter Exclusive Deal Negotiations -- 7th Update

5 dic 2025, 21:12 UTC

Charlas de Mercado

Natural Gas Surge 9% This Week on Strong Flow of Exports -- Market Talk

5 dic 2025, 21:03 UTC

Charlas de Mercado

Ganancias

Bank of Montreal Logs Solid Quarter, Though Some Unease Remains -- Market Talk

5 dic 2025, 21:01 UTC

Charlas de Mercado

Oil Caps Positive Week on Geopolitical Turmoil -- Market Talk

5 dic 2025, 20:43 UTC

Adquisiciones, fusiones, absorciones

Limitless CEO Siroker: Will No Longer Sell Pendant to New Customers

5 dic 2025, 20:43 UTC

Adquisiciones, fusiones, absorciones

Limitless CEO Siroker: Existing Pendant Customers to Be Supported for at Least Another Year

5 dic 2025, 20:42 UTC

Adquisiciones, fusiones, absorciones

Limitless CEO Dan Siroker: Limitless Has Been Acquired by Meta >META

5 dic 2025, 20:01 UTC

Adquisiciones, fusiones, absorciones

Netflix Landed a Big Deal. Now it Could Have a Big Fight. -- WSJ

5 dic 2025, 19:44 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

5 dic 2025, 19:44 UTC

Charlas de Mercado

Canada Dollar Gains Nearly 1% on Jobs Data, Rate Outlook -- Market Talk

5 dic 2025, 19:39 UTC

Charlas de Mercado

Silver Climbs to a New Record High -- Market Talk

5 dic 2025, 19:31 UTC

Adquisiciones, fusiones, absorciones

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

5 dic 2025, 18:30 UTC

Charlas de Mercado

Canada Jobless Rate Can Fall More Before Labor Slack Disappears -- Market Talk

5 dic 2025, 18:28 UTC

Adquisiciones, fusiones, absorciones

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

5 dic 2025, 18:24 UTC

Adquisiciones, fusiones, absorciones

AMC and IMAX Stocks Drop. Roku Rises. How the Netflix-Warner Bros. Deal Could Shake Up Entertainment. -- Barrons.com

5 dic 2025, 18:20 UTC

Charlas de Mercado

Baker Hughes Reports Higher U.S. Rig Count -- Market Talk

5 dic 2025, 18:11 UTC

Charlas de Mercado

The Tale of Two Canadian Employment Indicators -- Market Talk

5 dic 2025, 17:48 UTC

Charlas de Mercado

Canadian Youth Unemployment Rate Cools -- Market Talk

5 dic 2025, 17:44 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Global Equities Roundup: Market Talk

5 dic 2025, 17:44 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Correction to Imax Market Talk

5 dic 2025, 17:35 UTC

Charlas de Mercado

Canada Jobs Data Doesn't Jive With Trade Uncertainty, Indicators -- Market Talk

5 dic 2025, 17:25 UTC

Charlas de Mercado

Canadian Jobs Numbers May Support Rates Hikes Next Year -- Market Talk

Comparación entre iguales

Cambio de precio

Lexicon Pharmaceuticals Inc previsión

Precio Objetivo

By TipRanks

179.58% repunte

Estimación a 12 Meses

Media 3.97 USD 179.58%

Máximo 6 USD

Mínimo 1.9 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Lexicon Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para Lexicon Pharmaceuticals Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

0.6863 / 0.72Soporte y Resistencia

Recent bearish events outweigh bullish events.

All events are bullish.

There is one bearish event.

Sentimiento

By Acuity

184 / 374 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.